Over-expression of drug efflux transporters at the level of the blood-brain barrier (BBB) has been proposed as a mechanism responsible for multidrug resistance. Drug transporters in epileptogenic tissue are not only expressed in endothelial cells at the BBB, but also in other brain parenchymal cells, such as astrocytes, microglia and neurons, suggesting a complex cell type-specific regulation under pathological conditions associated with epilepsy. This review focuses on the cerebral expression patterns of several classes of well-known membrane drug transporters such as P-glycoprotein (Pgp), and multidrug resistance-associated proteins (MRPs) in the epileptogenic brain. Both experimental and clinical evidence of epilepsy-associated cerebral ...
Pharmacoresistance is a major clinical challenge for approximately 30% of patients with epilepsy. Pr...
International audiencePharmacoresistance is a major clinical challenge for approximately 30% of pati...
Epilepsy affects more than 60 million people worldwide. While most patients can be treated with anti...
Abstract Background Permeability of the blood-brain barrier is one of the factors determining the bi...
PURPOSE: Overexpression of multidrug transporters may play a role in the development of pharmacoresi...
The diploma thesis summarizes the recent knowledge on the possible role ABC transporters in mechanis...
The diploma thesis summarizes the recent knowledge on the possible role ABC transporters in mechanis...
Purpose: Overexpression of multidrug transporters may play a role in the development of pharmacoresi...
Resistance to antiepileptic drugs (AED) remains a major problem in clinical epileptology. This pharm...
SummaryRecent arouse of interest indicated that drug resistant proteins are markedly over-expressed ...
A cure for epilepsy is currently not available, and seizure genesis, seizure recurrence, and resista...
keine AngabenSlices of human cortical tissue from epilepsy surgery were investigated. This were pati...
SummaryRecent arouse of interest indicated that drug resistant proteins are markedly over-expressed ...
Pharmacoresistance is a major clinical challenge for approximately 30% of patients with epilepsy. Pr...
The multidrug resistance (MDR) phenotype is typically observed in patients with refractory epilepsy ...
Pharmacoresistance is a major clinical challenge for approximately 30% of patients with epilepsy. Pr...
International audiencePharmacoresistance is a major clinical challenge for approximately 30% of pati...
Epilepsy affects more than 60 million people worldwide. While most patients can be treated with anti...
Abstract Background Permeability of the blood-brain barrier is one of the factors determining the bi...
PURPOSE: Overexpression of multidrug transporters may play a role in the development of pharmacoresi...
The diploma thesis summarizes the recent knowledge on the possible role ABC transporters in mechanis...
The diploma thesis summarizes the recent knowledge on the possible role ABC transporters in mechanis...
Purpose: Overexpression of multidrug transporters may play a role in the development of pharmacoresi...
Resistance to antiepileptic drugs (AED) remains a major problem in clinical epileptology. This pharm...
SummaryRecent arouse of interest indicated that drug resistant proteins are markedly over-expressed ...
A cure for epilepsy is currently not available, and seizure genesis, seizure recurrence, and resista...
keine AngabenSlices of human cortical tissue from epilepsy surgery were investigated. This were pati...
SummaryRecent arouse of interest indicated that drug resistant proteins are markedly over-expressed ...
Pharmacoresistance is a major clinical challenge for approximately 30% of patients with epilepsy. Pr...
The multidrug resistance (MDR) phenotype is typically observed in patients with refractory epilepsy ...
Pharmacoresistance is a major clinical challenge for approximately 30% of patients with epilepsy. Pr...
International audiencePharmacoresistance is a major clinical challenge for approximately 30% of pati...
Epilepsy affects more than 60 million people worldwide. While most patients can be treated with anti...